SPDR S&P Pharmaceuticals ETF Rating $64.45 +1.24 (+1.96%) As of 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy 2.65Holdings in XPH have an aggregate rating of Moderate Buy based on 272 analyst ratings issued in the past year covering 25 companies (56.9% of the portfolio).XPH Aggregate Price Target$64.45High Prediction$64.45Average Prediction$64.45Low Prediction$64.45Holdings in XPH have an aggregate price target of $64.45 and a range of $64.45 to $64.45 covering 25 companies (56.9% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 XPH Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.35%CORTCorcept Therapeutics$81.56+2.1%3.4447 of 5 stars2.75$88.83 8.9%83.68%OGNOrganon & Co.$13.47+0.1%2.6716 of 5 stars1.71$11.40 -15.3%73.09%LQDALiquidia$75.54+2.0%3.428 of 5 stars2.90$67.43 -10.7%10Analyst ForecastInsider Trade2.77%AXSMAxsome Therapeutics$237.92-1.7%2.4763 of 5 stars2.95$258.95 8.8%21Positive News2.43%ELVNEnliven Therapeutics$47.77-1.7%2.6771 of 5 stars2.83$63.40 32.7%6Insider Trade2.39%MBXMBX Biosciences$48.40+4.3%1.7962 of 5 stars2.77$60.22 24.4%132.28%DFTXDefinium Therapeutics$42.13+16.4%2.216 of 5 stars3.00$47.08 11.7%17Trending NewsAnalyst ForecastAnalyst RevisionGap UpHigh Trading Volume2.26%TRVITrevi Therapeutics$17.43+0.3%2.5703 of 5 stars3.00$22.90 31.4%12News CoverageHigh Trading Volume2.24%AMRXAmneal Pharmaceuticals$17.27+3.7%1.7896 of 5 stars2.71$15.80 -8.5%7News CoverageAnalyst Upgrade2.15%JAZZJazz Pharmaceuticals$229.85-0.2%3.416 of 5 stars2.79$246.06 7.1%192.06%ESPREsperion Therapeutics$3.15-0.3%3.3489 of 5 stars2.00$5.54 75.9%8News Coverage2.06%HRMYHarmony Biosciences$34.45+0.8%4.0443 of 5 stars2.27$40.89 18.7%11Analyst Upgrade2.04%RPRXRoyalty Pharma$54.24-2.0%4.542 of 5 stars3.00$53.71 -1.0%7Positive News2.03%INDVIndivior$41.47+3.8%2.1602 of 5 stars3.00$40.29 -2.9%8Analyst Upgrade2.02%LGNDLigand Pharmaceuticals$284.91+2.0%2.4969 of 5 stars2.88$257.71 -9.5%82.01%VTRSViatris$15.93+1.1%2.9733 of 5 stars2.57$17.50 9.9%7News Coverage2.00%XERSXeris Biopharma$7.40+2.8%3.328 of 5 stars2.43$10.80 45.9%7Positive News1.97%LLYEli Lilly and Company$1,115.98+0.8%4.5885 of 5 stars2.87$1,230.89 10.3%30Trending NewsDividend AnnouncementAnalyst ForecastGap Up1.96%NUVBNuvation Bio$6.52+8.0%3.5238 of 5 stars2.55$12.50 91.7%11High Trading Volume1.92%EWTXEdgewise Therapeutics$42.30+8.9%1.6704 of 5 stars2.78$47.30 11.8%91.91%ANIPANI Pharmaceuticals$82.72-0.3%4.4062 of 5 stars2.75$107.33 29.8%8Positive NewsAnalyst Upgrade1.91%PRGOPerrigo$9.77+2.9%3.825 of 5 stars2.00$19.33 98.0%61.82%HROWHarrow$42.68-0.2%4.3011 of 5 stars2.64$69.43 62.7%111.81%ELANElanco Animal Health$23.96+3.4%3.7662 of 5 stars2.79$28.55 19.2%14Positive News1.77%INVAInnoviva$23.64+0.4%3.4148 of 5 stars2.57$36.20 53.1%7Trending NewsAnalyst ForecastAnalyst Revision This page (NYSEARCA:XPH) was last updated on 6/24/2026 by MarketBeat.com Staff. From Our PartnersFirm That Predicted 2008, 2020, 2022: Right Now Looks WorseThe firm that predicted the dot-com crash, the 2008 financial crisis, the 2020 COVID crash, and the 2022 bear ...TradeSmith | SponsoredThe Treasury just bought its own debtOn April 16th, the U.S. Treasury executed a $15 billion buyback of its own debt - the largest in history - whi...Golden Portfolio | SponsoredElon’s message for AmericaElon Musk bought Super Bowl ad time at $266,000 per second - something he has never done before. 125 million A...Stansberry Research | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely, LLC | SponsoredBuy this stock todayMarc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...Chaikin Analytics | SponsoredVWAV: An Under-the-Radar Defense PlayVisionWave Holdings (NASDAQ: VWAV) is developing a multi-domain defense platform combining AI-powered analytic...Equiscreen | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XPH Stock Alerts